Sonic Healthcare (OTCMKTS:SKHHY) Stock Rating Upgraded by Zacks Research

Sonic Healthcare (OTCMKTS:SKHHY) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday, Zacks reports.

Separately, The Goldman Sachs Group downgraded shares of Sonic Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, October 11th. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Reduce”.

Sonic Healthcare Price Performance

Sonic Healthcare stock opened at $13.08 on Monday. The company’s 50 day simple moving average is $13.87 and its 200 day simple moving average is $14.15. Sonic Healthcare has a fifty-two week low of $12.58 and a fifty-two week high of $17.49.

About Sonic Healthcare

Sonic Healthcare Limited is an Australian healthcare company specializing in medical diagnostics. Its principal business is laboratory medicine, providing pathology and clinical testing services used to diagnose, monitor and manage a broad range of medical conditions. The company serves hospitals, physicians, healthcare organizations and patients through networks of medical laboratories and collection centers.

Sonic Healthcare also operates medical imaging businesses in selected markets and provides related healthcare services, including occupational health and primary care offerings in Australia.